These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37348816)

  • 1. Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: a randomized controlled trial.
    Awomolo AM; McWhirter A; Sadler LC; Coppola LM; Hill MG
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101064. PubMed ID: 37348816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal outcomes from a randomized controlled trial of maternal treatment of iron deficiency anemia with intravenous ferumoxytol vs oral ferrous sulfate.
    Awomolo AM; McWhirter A; Sadler LC; Coppola LM; Hill MG
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101063. PubMed ID: 37348817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
    Macdougall IC; Strauss WE; McLaughlin J; Li Z; Dellanna F; Hertel J
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):705-12. PubMed ID: 24458078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.
    Provenzano R; Schiller B; Rao M; Coyne D; Brenner L; Pereira BJ
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):386-93. PubMed ID: 19176796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease.
    Schwenk MH
    Pharmacotherapy; 2010 Jan; 30(1):70-9. PubMed ID: 20030475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial.
    Powers JM; Buchanan GR; Adix L; Zhang S; Gao A; McCavit TL
    JAMA; 2017 Jun; 317(22):2297-2304. PubMed ID: 28609534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study.
    Ortiz R; Toblli JE; Romero JD; Monterrosa B; Frer C; Macagno E; Breymann C
    J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1347-52. PubMed ID: 21859366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.
    Vadhan-Raj S; Strauss W; Ford D; Bernard K; Boccia R; Li J; Allen LF
    Am J Hematol; 2014 Jan; 89(1):7-12. PubMed ID: 23983177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.
    Lu M; Cohen MH; Rieves D; Pazdur R
    Am J Hematol; 2010 May; 85(5):315-9. PubMed ID: 20201089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intermittent iron treatment of two- to six-year-old Jordanian children with iron-deficiency anemia.
    Faqih AM; Kakish SB; Izzat M
    Food Nutr Bull; 2006 Sep; 27(3):220-7. PubMed ID: 17542112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferumoxytol for treating iron deficiency anemia in CKD.
    Spinowitz BS; Kausz AT; Baptista J; Noble SD; Sothinathan R; Bernardo MV; Brenner L; Pereira BJ
    J Am Soc Nephrol; 2008 Aug; 19(8):1599-605. PubMed ID: 18525001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency.
    Cohen J; Khudanyan A; Lu J; Wing J; Olson S; Deloughery T; Shatzel JJ
    Am J Hematol; 2020 Dec; 95(12):1572-1577. PubMed ID: 32918335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    Hetzel D; Strauss W; Bernard K; Li Z; Urboniene A; Allen LF
    Am J Hematol; 2014 Jun; 89(6):646-50. PubMed ID: 24639149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
.
    Macdougall IC; Strauss WE; Dahl NV; Bernard K; Li Z
    Clin Nephrol; 2019 Apr; 91(4):237-245. PubMed ID: 30802204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous versus Oral Iron for Iron-Deficiency Anemia in Pregnancy (IVIDA): A Randomized Controlled Trial.
    Lewkowitz AK; Stout MJ; Cooke E; Deoni SC; D'Sa V; Rouse DJ; Carter EB; Tuuli MG
    Am J Perinatol; 2022 Jun; 39(8):808-815. PubMed ID: 34839481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of oral iron bisglycinate to intravenous iron sucrose for the treatment of postpartum anemia-randomized controlled trial.
    Yefet E; Mruat Rabah S; Sela ND; Hosary Mhamed S; Yossef A; Nachum Z
    Am J Obstet Gynecol; 2021 Dec; 225(6):668.e1-668.e9. PubMed ID: 34171389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial.
    Al RA; Unlubilgin E; Kandemir O; Yalvac S; Cakir L; Haberal A
    Obstet Gynecol; 2005 Dec; 106(6):1335-40. PubMed ID: 16319260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
    Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.